Davis Scott G.
SEC Form 4 insider trading activity
Davis Scott G. has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including CHRN, EKSO, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: May 18, 2026.
On the most recent filing, Davis Scott G. is listed as CEO at EKSO BIONICS HOLDINGS, INC. Inside the rolling window, Davis Scott G. reported no open-market purchases and 1 open-market sale totaling $112K in EKSO.
Companies traded
Other insiders at CHRN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$112K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Davis Scott G. made?
Davis Scott G. has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including CHRN, EKSO since 2025.
Which companies does Davis Scott G. trade?
Davis Scott G. has filed SEC Form 4 disclosures for 2 companies, including CHRN, EKSO.
When was Davis Scott G.'s most recent SEC Form 4 filing?
Davis Scott G.'s most recent SEC Form 4 filing on Tracefour is dated May 18, 2026.
What is Davis Scott G.'s total buy and sell value in the current window?
Inside the rolling retention window, Davis Scott G. bought $0 and sold $112K based on SEC Form 4 filings.
What was Davis Scott G.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 23,315 EKSO shares on 2025-11-10, worth $112K, per SEC Form 4 filings.